Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62,500,000
-
Total 13F shares
-
22,950,846
-
Share change
-
+629,621
-
Total reported value
-
$488,859,942
-
Price per share
-
$21.34
-
Number of holders
-
67
-
Value change
-
+$12,792,627
-
Number of buys
-
37
-
Number of sells
-
30
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q3 2015
As of 30 Sep 2015,
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,950,846 shares.
The largest 10 holders included
Third Rock Ventures, LLC, FMR LLC, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, Partner Fund Management, L.P., Visium Asset Management, LP, LORD, ABBETT & CO. LLC, RS INVESTMENT MANAGEMENT CO LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and CITADEL ADVISORS LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.